IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study) (EASED)
This study has been completed.
Sponsor:
Adamas Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Adamas Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT01397422
First received: July 18, 2011
Last updated: February 15, 2017
Last verified: February 2017
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | October 2013 |
| Primary Completion Date: | May 2013 (Final data collection date for primary outcome measure) |
| Certification or Request for Extension to Delay Results Received: | April 7, 2014 |